| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Renal Physiology, Vol 265, Issue 6 886-F895, Copyright © 1993 by American Physiological Society
ARTICLES |
J. P. Tolins, P. J. Shultz, L. Raij, D. M. Brown and S. M. Mauer
Department of Internal Medicine, University of Minnesota School of Medicine, Minneapolis 55455.
Diabetic rats manifest abnormal renal hemodynamic responses, with persistent renal vasodilation at reduced renal perfusion pressures. We hypothesized that in diabetes, renal hemodynamics are modulated by increased activity of the endogenous vasodilator, NO. In anesthetized Munich-Wistar rats, after 6 wk of streptozotocin-induced, insulin-treated diabetes, and in age-matched, nondiabetic littermates (n = 7-8), basal renal hemodynamics and responses to graded reductions in renal perfusion pressure were determined before and after intrarenal arterial infusion of the NO synthase inhibitor, NG-nitro-L-arginine methyl ester (L-NAME). An identical protocol was followed in a second cohort of rats pretreated with indomethacin (4 mg/kg iv). Diabetic rats demonstrated hyperglycemia, renal enlargement, hyperfiltration, and increased urinary excretion of the stable NO metabolites, NO2 and NO3. L-NAME eliminated basal hyperfiltration in diabetic rats, and L-NAME, but not indomethacin, also eliminated persistent renal vasodilation at reduced renal perfusion pressure. We conclude that in a rat model of diabetes, increased endogenous NO activity may play a role in basal hyperfiltration and in the persistent renal vasodilatation manifested at reduced renal perfusion pressures.
This article has been cited by other articles:
|
|
 |
|
  T. D. Bell, G. F. DiBona, R. Biemiller, and M. W. Brands Continuously measured renal blood flow does not increase in diabetes if nitric oxide synthesis is blocked Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1449 - F1456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhang, H. Meng, Z.-H. Li, Z. Shu, X. Ma, and B.-X. Zhang Regulation of STIM1, store-operated Ca2+ influx, and nitric oxide generation by retinoic acid in rat mesangial cells Am J Physiol Renal Physiol, March 1, 2007; 292(3): F1054 - F1064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Thomson, A. Deng, N. Komine, J. S. Hammes, R. C. Blantz, and F. B. Gabbai Early diabetes as a model for testing the regulation of juxtaglomerular NOS I Am J Physiol Renal Physiol, October 1, 2004; 287(4): F732 - F738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Komers and S. Anderson Paradoxes of nitric oxide in the diabetic kidney Am J Physiol Renal Physiol, June 1, 2003; 284(6): F1121 - F1137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. ISHII, K. P. PATEL, P. H. LANE, T. TAYLOR, K. BIAN, F. MURAD, J. S. POLLOCK, and P. K. CARMINES Nitric Oxide Synthesis and Oxidative Stress in the Renal Cortex of Rats with Diabetes Mellitus J. Am. Soc. Nephrol., August 1, 2001; 12(8): 1630 - 1639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Martínez-Nieves and J. C. Dunbar The Effect of Diabetes and Sex on Nitric Oxide-Mediated Cardiovascular Dynamics Experimental Biology and Medicine, January 1, 2001; 226(1): 37 - 42. [Abstract] [Full Text]
|
|
|
|
|
|
R. Komers, J. N. Lindsley, T. T. Oyama, K. M. Allison, and S. Anderson Role of neuronal nitric oxide synthase (NOS1) in the pathogenesis of renal hemodynamic changes in diabetes Am J Physiol Renal Physiol, September 1, 2000; 279(3): F573 - F583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. G. Seo, T. Nishinaka, and C. Yabe-Nishimura Nitric Oxide Up-Regulates Aldose Reductase Expression in Rat Vascular Smooth Muscle Cells: A Potential Role for Aldose Reductase in Vascular Remodeling Mol. Pharmacol., April 1, 2000; 57(4): 709 - 717. [Abstract] [Full Text]
|
|
|
|
|
|
R. A. Kramp, P. Fourmanoir, L. Ladriere, E. Joly, C. Gerbaux, A. el Hajjam, and N. Caron Effects of Ca2+ channel activity on renal hemodynamics during acute attenuation of NO synthesis in the rat Am J Physiol Renal Physiol, April 1, 2000; 278(4): F561 - F569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Schoonmaker, R. W. Fallet, and P. K. Carmines Superoxide anion curbs nitric oxide modulation of afferent arteriolar ANG II responsiveness in diabetes mellitus Am J Physiol Renal Physiol, February 1, 2000; 278(2): F302 - F309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Komers, T. T. Oyama, J. G. Chapman, K. M. Allison, and S. Anderson Effects of Systemic Inhibition of Neuronal Nitric Oxide Synthase in Diabetic Rats Hypertension, February 1, 2000; 35(2): 655 - 661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. VEELKEN, K. F. HILGERS, A. HARTNER, A. HAAS, K. P. BÖHMER, and R. B. STERZEL Nitric Oxide Synthase Isoforms and Glomerular Hyperfiltration in Early Diabetic Nephropathy J. Am. Soc. Nephrol., January 1, 2000; 11(1): 71 - 79. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Wang, S. Kikuchi, H. Suzuki, S. Nagase, and A. Koyama Endothelial nitric oxide synthase gene polymorphism in intron 4 affects the progression of renal failure in non-diabetic renal diseases Nephrol. Dial. Transplant., December 1, 1999; 14(12): 2898 - 2902. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Martínez-Nieves and J. C. Dunbar Vascular Dilatatory Responses to Sodium Nitroprusside (SNP) and {alpha}-Adrenergic Antagonism in Female and Male Normal and Diabetic Rats Experimental Biology and Medicine, October 2, 1999; 222(1): 90 - 98. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Kawagishi, M. Matsuyoshi, M. Emoto, H. Taniwaki, H. Kanda, Y. Okuno, M. Inaba, E. Ishimura, Y. Nishizawa, and H. Morii Impaired Endothelium-Dependent Vascular Responses of Retinal and Intrarenal Arteries in Patients With Type 2 Diabetes Arterioscler. Thromb. Vasc. Biol., October 1, 1999; 19(10): 2509 - 2516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Pflueger, T. S. Larson, S. Hagl, and F. G. Knox Role of nitric oxide in intrarenal hemodynamics in experimental diabetes mellitus in rats Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1999; 277(3): R725 - R733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-Z. Zhang and C. Baylis Endothelin mediates renal vascular memory of a transient rise in perfusion pressure due to NOS inhibition Am J Physiol Renal Physiol, April 1, 1999; 276(4): F629 - F634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Pflueger, H. Osswald, and F. G. Knox Adenosine-induced renal vasoconstriction in diabetes mellitus rats: role of nitric oxide Am J Physiol Renal Physiol, March 1, 1999; 276(3): F340 - F346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Pieper Review of Alterations in Endothelial Nitric Oxide Production in Diabetes : Protective Role of Arginine on Endothelial Dysfunction Hypertension, May 1, 1998; 31(5): 1047 - 1060. [Full Text] [PDF]
|
|
|
|
|
|
C. Qiu, K. Engels, L. Samsell, and C. Baylis Renal Effects of Acute Amino Acid Infusion in Hypertension Induced by Chronic Nitric Oxide Blockade Hypertension, January 1, 1995; 25(1): 61 - 66. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
